Elective single embryo transfer boosts the chance of a healthy baby

December 22, 2010 By Jennifer Phillips

Women who undergo elective single embryo transfer as part of in-vitro fertlisation (IVF) are five times more likely to give birth to a healthy baby compared with double embryo transfer, finds a new study published on bmj.com today.

The study recommends that clinicians should, from now on, advise women to have an elective single (eSET) as part of treatment rather than a double embryo transfer (DET).

Although there has been increasing success in treatments in recent years, there have also been growing concerns about rising rates of multiple pregnancies, which are associated with increased maternal and perinatal illness and death, as well as increased costs to the health service.

A previous review of studies comparing data on eSET versus DET concluded that, although eSET reduced the odds of , it halved the odds of per fresh cycle of treatment.

However, there has been, until now, a lack of evidence about the effect of single versus double embryo transfer in different groups of women and on outcomes such as miscarriage, and low birth weight.

So an international team of researchers, led by the University of Aberdeen, studied data on 1,367 women from eight eligible trials. A total of 683 and 684 women were randomised to the eSET and DET groups for this analysis.

This showed that in 27% (181 out of 683) of women who underwent a fresh IVF cycle using a single embryo transfer, they gave birth to a healthy baby, compared with 42% (285 out of 683) of women who had a healthy baby following double embryo transfer.

However, the gap between the two types of embryo transfer leading to successful births was much closer when an additional frozen single embryo was transferred at a later date following the first eSET - resulting in a 38% successful birth rate, compared with a 42% birth rate in double embryo transfer cases.

Results showed that the chances of a full-term single birth (over 37 weeks) following single embryo transfer were almost five times higher than those following double embryo transfer.

Single embryo transfer was also seen to reduce the risk of premature births — pregnant women were 87% more likely to avoid a premature birth before 37 weeks, having had a single embryo transfer.

The chance of delivering a baby with for single embryo transfer cases was a third of the chance for double embryo transfer cases.

Although adopting a strategy of always giving a single embryo transfer yielded a lower pregnancy rate than giving them double embryo transfer in a fresh IVF cycle, the difference was almost completely overcome by an additional frozen single embryo transfer cycle.

The researchers conclude: “Our review should be useful in informing decision making regarding the number of to transfer in IVF. Given the opportunity for replacing a single frozen thawed embryo in a subsequent cycle, elective single embryo transfer should thus be the default position.”

In an accompanying editorial, Allan Templeton, Professor of Obstetrics and Gynaecology at the University of Aberdeen asks: why have we not adopted this approach in the UK? He argues that in a commercially competitive environment, “clinicians have been distracted by success rates and do not see the more important healthy outcomes.”

He concludes: “At a time when the beginning of assisted reproduction is being recognized as an outstanding contribution to medical science, practitioners have a responsibility to develop its use wisely. Doctors managing infertile couples are no longer entitled to take risks with the health of the next generation.”

More information: Click here to view paper: www.bmj.com/cgi/doi/10.1136/bmj.c6945

Related Stories

Recommended for you

Researchers discover key signaling protein for muscle growth

November 20, 2017
Researchers at the University of Louisville have discovered the importance of a well-known protein, myeloid differentiation primary response gene 88 (MyD88), in the development and regeneration of muscles. Ashok Kumar, Ph.D., ...

New breast cell types discovered by multidisciplinary research team

November 20, 2017
A joint effort by breast cancer researchers and bioinformaticians has provided new insights into the molecular changes that drive breast development.

Brain cell advance brings hope for Creutzfeldt-Jakob disease

November 20, 2017
Scientists have developed a new system to study Creutzfeldt-Jakob disease in the laboratory, paving the way for research to find treatments for the fatal brain disorder.

Hibernating ground squirrels provide clues to new stroke treatments

November 17, 2017
In the fight against brain damage caused by stroke, researchers have turned to an unlikely source of inspiration: hibernating ground squirrels.

Age and gut bacteria contribute to multiple sclerosis disease progression

November 17, 2017
Researchers at Rutgers Robert Wood Johnson Medical School published a study suggesting that gut bacteria at young age can contribute to multiple sclerosis (MS) disease onset and progression.

Molecular guardian defends cells, organs against excess cholesterol

November 16, 2017
A team of researchers at the Harvard T. H. Chan School of Public Health has illuminated a critical player in cholesterol metabolism that acts as a molecular guardian in cells to help maintain cholesterol levels within a safe, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.